A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT03215030 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

272

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by the sponsor for strategic reasons

Conditions

Multiple Myeloma

Interventions

DRUG: Modakafusp alfa
DRUG: Dexamethasone

Sponsor

Teva Branded Pharmaceutical Products R&D LLC